Marksans Pharma Ltd. — Capital/Financing Update 2024

Nov 12, 2024

November 12, 2024

Corporate Relation Department Listing Department Phiroze Jeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Scrip Code: 524404 Symbol: MARKSANS

BSE Limited National Stock Exchange of India Limited

Mumbai - 400001. Bandra (East), Mumbai - 400051.

Sub: Statement on Deviation or Variation of funds raised through Preferential Issue of Convertible Warrants.

Dear Sir/Madam,

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMDl/162/2019 dated December 24, 2019, we hereby confirm that there is no deviation or variation in the use of funds raised through Preferential Issue of Convertible Warrants from the objects stated in the Explanatory Statement to the Notice of Extra-Ordinary General Meeting of the Company dated 15th June, 2021.

Accordingly, a Nil Statement of Deviation, duly reviewed by the Audit Committee of the Company, for the Quarter ended September 30, 2024 is enclosed as "Annexure A".

We request you to take the aforesaid in your records.

Thanking You.

Yours faithfully, For Marksans Pharma Limited

HARSHAVARDH AN PANIGRAHI Digitally signed by HARSHAVARDHAN PANIGRAHI Date: 2024.11.12 13:22:20 +05'30'

Harshavardhan Panigrahi Company Secretary

Encl: As above

Statement of Deviation or Variation for the quarter ended September 30, 2024

Statement of Deviation/ Variation in utilization offunds raised
Name of listed entity	Marksans Pharma Limited
Mode of Fund Raising	Preferential Issue
Date of Raising Funds	20.07.2021 & 18.01.2023
Amount Raised	Rs. 3,72,39,99,976.00
Report filed for quarter ended	September 30, 2024
Monjtoring Agency	Not Applicable
Monitoring Agency Name, if aoolicable	Not Applicable
ls there a Deviation/ Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was aooroved by the shareholders	Not Applicable
If Yes, Date of shareholder Approval	Not Aoolicable
Explanation for the Deviation/ Variation	Not Applicable
Comments of the Audit Committee after review	No Comments
Comments of the auditors, if any	No Comments

Objects for which funds have been raised and where there has been a deviation, in the following table

Original Object	Modified Object, if any	Original Allocatio n as on 18111Januar y,2023 TnRs.	Modified allocation , if any	Funds utilised till September 30,2024 In Rs.	Amount of deviation/ variation for the quarter according to applicable object	Remarks if any
of The proceeds the preferential issue are proposed to be used to strengthen the capital base and toenhance long term financial resources of the Company in order to fund expansion program of the Company.	None	Rs. 3,72,39,9 9,976.00	None	2,48,40,55, 684.00	-	No deviations

Deviation or variation could mean:

offer, etc

• (a) Deviation in the objects or pu,posesfor which the funds have been raised or
• (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of
• rJ ,1 A , ~WM J0 MUMBAl-53

Name of Signatory - Harshavardhan Panigrahi Designation - Company Secretary & Compliance